Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN 1997-6933 (print)
ISSN 2500-2139 (online)
Русский English
  • Register
  • Login
Skip to main content Skip to main navigation menu Skip to site footer
Clinical Oncohematology
Basic Research and Clinical Practice

ИФ РИНЦ:     0,587
H-INDEX:        16

  • Home
  • About the Journal
    • Aims and Scope
    • Editorial Masthead
    • Peer Review
    • Publishing Ethics and Malpractice Statement
    • Indexing and Abstracting
    • Ownership, management and funding
    • Open Access Policy and Publication Fee
  • Articles
    • Current
    • Journal pre-proofs
    • Archive
    • SUPPLEMENT
  • Sections
    • LYMPHOID TUMORS
    • MYELOID TUMORS
    • BONE MARROW TRANSPLANTATION
    • ANEMIAS
    • AUTOIMMUNE DISEASES
    • CLINICAL TRIALS
    • NOVEL CORONAVIRUS INFECTION
    • NEWS
    • NEW TECHNOLOGIES
    • REVIEWS
    • COMPLICATIONS OF CHEMOTHERAPY
    • PRACTICAL RECOMMENDATIONS
    • RARE HEMATOLOGICAL TUMORS AND SYNDROMES
    • EXPERIMENTAL STUDIES
  • Submission
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Treatment Efficacy for Pediatric Acute Myeloid Leukemias: Results of a Single-Center Trial

    E.V. Inyushkina, Sergei Olegovich Gunyakov, A.V. Bogucharskii, V.O. Stepanova
    142-151
    01.04.2026
  • Quality of Life and Symptom Profile in Polycythemia Vera Patients on Ruxolitinib Therapy in a Real-World Setting: Results of a Multi-Center Prospective Observational Study

    T.I. Ionova, Tatyana Pavlovna Nikitina, A.V. Proidakov, E.V. Lyurova, E.M. Volodicheva, L.A. Mkhitaryan, Yu.P. Martinova, T.V. Chitanava, N.B. Esefeva, M.O. Ivanova, T.I. Pospelova, A.S. Lyamkina, E.A. Knyazeva, E.G. Lomaia, N.S. Lazorko, K.P. Novoselov, D.A. Lipatova, N.M. Porfirieva, A.D. Kulagin
    14-26
    01.01.2026
  • Clinical Features and Treatment Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma

    Anastasia Borisovna Galitsyna, N.A. Falaleeva, O.V. Levkovskiy, V.A. Shuvaev, A.Yu. Terekhova, M.G. Syadrin, E.A. Norot, A.M. Chelmakov, S.A. Ivanov, A.D. Kaprin
    49-58
    01.01.2026
  • The Optimal Background Cut-Off Threshold for Calculating Volumetric PET Biomarkers as Prognostic Factors in Classical Hodgkin Lymphoma

    Mariya Vasilevna Metelkina, I.P. Aslanidi, O.V. Mukhortova, D.M. Pursanova, V.A. Manukova, I.V. Shurupova, T.A. Trifonova, D.D. Zubkov, A.S. Rumyantsev
    39-48
    01.01.2026
  • Treatment Opportunities in Epstein-Barr Virus-Associated Chronic Active Disease and Secondary Hemophagocytic Syndrome: A Case Series

    Vsevolod Gennadevich Potapenko, M.M. Antonov, D.D. Avdoshina, M.M. Aksenova, V.V. Baykov, M.B. Belogurova, I.A. Bekhtereva, L.V. Glyzhina, E.N. Dulaeva, Yu.V. Zabutova, V.E. Karev, N.A. Kotova, V.V. Kozyro, Yu.A. Krivolapov, T.G. Kulibaba, S.V. Lapin, E.E. Leenman, N.B. Mikhailova, S.I. Moiseev, A.A. Molchan, M.Yu. Pervakova, M.S. Petrova, O.P. Petrova, N.A. Potikhonova, V.V. Ryabchikova, D.R. Rakhimzyanova, I.A. Samorodova, A.V. Serkov, I.A. Skorokhod, K.V. Skoriukova, N.V. Skorobogatova, I.M. Slashcheva, E.A. Surkova, D.R. Smirnov, M.N. Smirnova, O.P. Mironova, O.V. Nebelitskaia, Yu.A. Nesterov, I.P. Fedunyak, A.N. Kholodnaia, N.Yu. Chernookaya, D.A. Chaginskaya, N.V. Medvedeva
    355-371
    01.10.2025
  • The Prognostic Value of Minimal Residual Disease Assessed During the Remission Induction Stage in Acute Myeloid Leukemia Patients

    Irina Vladimirovna Galtseva, E.N. Parovichnikova, Yu.O. Davydova, N.M. Kapranov, K.A. Nikiforova, Yu.A. Chabaeva, L.A. Kuzmina, I.A. Lukianova, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov
    233-241
    01.07.2025
  • Which Calculations Are Required for Treating Patients with Multiple Myeloma?

    Aleksander Sergeevich Luchinin, A.A. Semenova
    218-226
    01.07.2025
  • Comparative Efficacy Analysis of Mobilization and Collection of Autologous Hematopoietic Stem Cells in Patients with Lymphoproliferative Disorders and Multiple Sclerosis

    Oksana Vladimirovna Fedyk, V.O. Sarzhevskii, D.A. Fedorenko, V.Ya. Mel’nichenko, Yu.N. Dubinina, N.E. Mochkin, E.G. Smirnova, D.S. Kolesnikova, A.E. Bannikova
    51-58
    01.07.2025
  • Current Strategy and Principles of Multiple Myeloma Treatment: A Literature Review

    Aleksander Sergeevich Luchinin, A.A. Semenova, S.V. Semochkin
    153-162
    01.04.2025
  • Options for Program Chemotherapy and Their Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Based on the Data from a Single Center

    Ulyana Gordeevna Koshkina, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, N.A. Kupryshina, E.A. Osmanov
    121-133
    01.04.2025
  • Esophagogastric Bleedings in Patients with Ph-Negative Myeloproliferative Neoplasms and Extrahepatic Portal Hypertension

    Pavel Artemovich Batrov, K.I. Danishian, E.P. Sysoeva, K.R. Sabirov, O.M. Averbukh, O.A. Soboleva, E.A. Kitsenko, E.A. Lukina
    163-170
    01.04.2025
  • Anti-CD38 Antibodies in Monotherapy for Patients with Relapsed/Refractory Multiple Myeloma: Real-World Clinical Practice and Results of Clinical Trials

    Margarita Andreevna Ulyanova, V.I. Vorobyev, L.A. Bychenkova, S.V. Semochkin
    145-152
    01.04.2025
  • Personalized Approach to Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients with Respect to Molecular Landscape: A Case Report and Literature Review

    Marat Albertovich Mingalimov, E.A. Baryakh, T.N. Tolstykh, A.V. Misyurin, L.A. Kesaeva, A.S. Mkrtchyan, A.M. Kovrigina, E.N. Misyurina, M.S. Orlova, T.S. Chudnova, D.D. Ivanova, O.L. Kochneva, S.S. Andreev, K.V. Yatskov, I.V. Samsonova, M.A. Lysenko
    177-183
    01.04.2025
  • Treatment Outcomes in Primary Mediastinal Large B-Cell Lymphoma. Experience of the AF Tsyb Medical Radiological Research Center (Obninsk)

    Alena Yurevna Terekhova, N.A. Falaleeva, A.B. Galitsyna, A.M. Chelmakov, A.A. Vovchenko, N.A. Riabikina, A.A. Danilenko, T. I. Bogatyreva
    225-236
    01.07.2024
  • KRAS/NRAS Gene Mutations and the Efficacy of Bortezomib-Based Triplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

    Anna Mikhailovna Sergeeva, V.L. Surin, Yu.A. Chabaeva, A.A. Kraizman, M.V. Solovev, S.M. Kulikov, L.P. Mendeleeva
    256-265
    01.07.2024
  • Impact of Cardiac Disease on Prognosis in Patients with Systemic AL Amyloidosis

    Olga Vladislavovna Pirogova, O.V. Kudyasheva, M.V. Chernous, M.A. Gorodnova, D.K. Lamden, K.A. Novitskaya, A.G. Smirnova, A.V. Yakovleva, V.A. Ionin, A.M. Ananin, I.S. Moiseev, A.D. Kulagin
    237-245
    01.07.2024
  • Treatment of Patients with Local Stages of Newly Diagnosed Classical Hodgkin Lymphoma: A Literature Review, Current Approaches, and Our Own Experience

    Evgeniya Viktorovna Paramonova, Yu.I. Klyuchagina, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.V. Arakelyan, A.A. Semenova, E.A. Demina, O.P. Trofimova, A.S. Subbotin, M.A. Senchenko, G.S. Tumyan
    27-36
    17.05.2024
  • Nivo-DHAP Combined with Subsequent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Trial (ClinicalTrials.gov, NCT04091490)

    V.O. Sarzhevskii, Aisel Akifovna Mamedova, N.E. Mochkin, E.A. Demina, A.A. Spornik, A.A. Samoilova, V.S. Bogatyrev, A.A. Rukavitsyn, E.G. Smirnova, N.S. Shorokhov, A.E. Bannikova, V.Ya. Melnichenko, N.B. Mikhailova, E.S. Borzenkova, L.V. Stelmakh, Yu.R. Zalyalov, A.A. Semenova, G.S. Tumyan, M.A. Danilova, O.A. Konova, N.A. Falaleeva, AYu Terekhova, M.A. Vernyuk, A.M. Chervontseva, L.S. Khairullina, A.A. Maslov, I.B. Lysenko, Yu.A. Alekseeva, E.S. Pavlyuchenko, A.A. Mirsaitov, A.A. Zverkova, I.V. Ishmatova, S.A. Volchenkov, M.S. Motalkina, I.S. Zyuzgin
    1-10
    17.05.2024
  • BAALC-Expressing Leukemia Hematopoietic Stem Cells and Their Place in the Study of CBF-Positive Acute Myeloid Leukemias in Children and Adults

    M.M. Kanunnikov, Nikolai Nikolaevich Mamaev, T.L. Gindina, A.I. Shakirova, A.M. Sadykov, S.V. Razumova, S.N. Bondarenko, L.S. Zubarovskaya
    387-398
    28.09.2023
  • Follicular Lymphoma of Grades 1–3А With and Without t(14;18)(q32;q21): A Prognosis, Choice of Chemotherapy and Its Outcomes

    Ekaterina Sergeevna Nesterova, E.E. Zvonkov, A.M. Kovrigina, T.N. Obukhova, B.V. Biderman, A.B. Sudarikov, Ya.K. Mangasarova, A.U. Magomedova, A.K. Smolyaninova, S.M. Kulikov, E.N. Parovichnikova
    361-369
    28.09.2023
  • Primary Prevention of Neutropenia by Empegfilgrastim in Patients with Advanced Stages of Classical Hodgkin Lymphoma Treated with Intensive First-Line Chemotherapy with a Modified 6-Cycle Program EACODD-14 Under the Protocol “LKh-Rossiya-1”

    Anna Anatolevna Spornik, N.S. Vasilev, A.A. Samoilova, A.A. Mamedova, V.S. Bogatyrev, E.G. Smirnova, A.A. Bannikova, A.A. Rukavitsyn, N.S. Shorokhov, N.E. Mochkin, V.O. Sarzhevskii, E.A. Demina, V.Ya. Melnichenko
    370-379
    28.09.2023
  • Treatment Outcomes with Asciminib, the First Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor, in Chronic Myeloid Leukemia Patients with Multiple Resistance to Prior Therapy

    A.G. Turkina, Elena Andreevna Kuzmina
    311-320
    09.06.2023
  • Long-Term Outcomes of Immunosuppressive Therapy for Aplastic Anemia: A Single-Center Experience

    Elena Romanovna Shilova, N.A. Romanenko, D.A. Chebykina, T.V. Glazanova, M.N. Zenina, I.E. Pavlova, S.S. Bessmeltsev
    321-330
    09.06.2023
  • Classical Hodgkin Lymphoma: Tumor Structure and Prognostic Value of the Immune Microenvironment

    Artem Aleksandrovich Gusak, K.V. Lepik, L.V. Fedorova, V.V. Markelov, V.V. Baykov
    242-262
    09.06.2023
  • Long-Term Results of Classical Hodgkin’s Lymphoma Treatment in Real-World Clinical Practice: Experience of Novosibirsk Hematological Unit

    Mariya Sergeevna Voitko, T.I. Pospelova, I.N. Nechunaeva, Ya.Yu. Shebunyaeva
    192-199
    03.03.2023
  • Efficacy and Toxicity of Induction Therapy in Patients with Newly Diagnosed Systemic AL Amyloidosis: Results of a Prospective Single-Center Clinical Study

    I.G. Rekhtina, Viktoriya Aleksandrovna Khyshova, M.V. Solov’ev, L.P. Mendeleeva
    166-173
    03.03.2023
  • The Role of Autologous Hematopoietic Stem Cell Transplantation in the Therapy of Systemic AL Amyloidosis

    Olga Vladislavovna Pirogova, O.V. Kudyasheva, A.G. Smirnova, V.V. Porunova, S.V. Tolstova, K.R. Kalimulina, M.V. Chernous, Yu.Yu. Vlasova, I.S. Moiseev, V.A. Dobronravov, A.D. Kulagin
    128-136
    03.03.2023
  • Efficacy of Combined Drug Pre-transplant Conditioning Regimens in Multiple Myeloma Patients with Single Autologous Hematopoietic Stem Cell Transplantation

    Ivan Ivanovich Kostroma, A.S. Zhuk, Zh.Yu. Sidorova, R.R. Sabitova, A.Yu. Aksenova, O.B. Belopolskaya, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev
    88-95
    01.01.2023
  • Prognostic Models in Medicine

    Aleksander Sergeevich Luchinin
    27-36
    01.01.2023
  • Characteristic Features of the Novel Coronavirus Infection COVID-19 in Oncohematological Patients

    Nikolai Aleksandrovich Romanenko, E.R. Shilova, L.V. Stelmashenko, E.I. Kaitandzhan, A.V. Kuleshova, N.P. Stizhak, V.N. Chebotkevich, S.V. Sidorkevich, S.V. Gritsaev, S.S. Bessmeltsev
    101-108
    01.01.2023
  • Acute Myeloid Leukemias After the Treatment of Classical Hodgkin’s Lymphoma: A Literature Review

    Anatolii Aleksandrovich Danilenko, S.V. Shakhtarina, N.A. Falaleeva
    414-423
    01.10.2022
  • Efficacy and Safety of Pola-BR Combination in Relapsed/Refractory Aggressive В-Cell Non-Hodgkin’s Lymphomas: A Russian Multi-Center Study

    Olesya Gennadevna Smykova, A.A. Semenova, Yu.B. Chernykh, T.A. Mitina, A.V. Kildyushevskii, S.K. Kravchenko, A.E. Misyurina, A.U. Magomedova, E.A. Baryakh, S.V. Samarina, N.P. Volkov, V.V. Markelov, P.V. Kotselyabina, L.V. Fedorova, K.V. Lepik, E.V. Kondakova, L.V. Stelmakh, V.V. Baykov, N.B. Mikhailova, I.S. Moiseev, G.S. Tumyan, E.A. Osmanov, A.D. Kulagin
    232-239
    01.07.2022
  • Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

    E.G. Lomaia, V.A. Shuvaev, Tamara Vangelevna Chitanava, Yu.D. Matvienko, I.S. Martynkevich, S.V. Voloshin, E.V. Efremova, E.S. Mileeva, M.S. Fominykh, A.E. Kersilova, E.V. Karyagina, N.V. Il’ina, N.V. Dorofeeva, N.V. Medvedeva, A.V. Klimovich, T.V. Shneider, S.A. Stepanova, N.F. Polezhaikovskaya, N.T. Siordiya, E.I. Sbityakova, N.S. Lazorko, E.N. Tochenaya, D.V. Motorin, N.A. Shnalieva, Yu.A. Alekseeva, D.B. Zammoeva, A.Yu. Zaritskey
    271-281
    01.07.2022
  • Protocol ALL-IC BFM 2002: Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment under Multi-Center Clinical Trial

    Timur Teimurazovich Valiev, M.A. Shervashidze, I.V. Osipova, T.I. Burlutskaya, N.A. Popova, N.S. Osmulskaya, G.A. Aleskerova, S.L. Sabantsev, Z.S. Gordeeva, V.Yu. Smirnov, O.A. Poberezhnaya, S.N. Yuldasheva, I.A. Babich, N.A. Batmanova, S.R. Varfolomeeva
    119-129
    01.04.2022
  • Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes with Trisomy 8 and/or Monosomy 7

    M.V. Latypova, Nikolai Nikolaevich Mamaev, T.L. Gindina, A.I. Shakirova, O.V. Paina, A.A. Osipova, T.V. Rudakova, E.V. Morozova, S.N. Bondarenko, L.S. Zubarovskaya
    198-204
    01.04.2022
  • Current Quality-of-Life Aspects in Patients with Classical Ph-Negative Myeloproliferative Neoplasms in the Russian Federation: Results and Discussion of the National Observational Program MPN-QoL-2020

    T.I. Ionova, E.A. Andreevskaya, E.N. Babich, N.B. Bulieva, O.Yu. Vinogradova, E.M. Volodicheva, S.V. Voloshin, N.N. Glonina, S.K. Dubov, N.B. Esef’eva, A.Yu. Zaritskey, E.E. Zinina, M.O. Ivanova, T.Yu. Klitochenko, A.V. Kopylova, A.D. Kulagin, G.B. Kuchma, O.Yu. Li, E.G. Lomaia, A.L. Melikyan, V.Ya. Melnichenko, S.N. Menshakova, N.V. Minaeva, T.A. Mitina, E.V. Morozova, Tatyana Pavlovna Nikitina, O.E. Ochirova, A.S. Polyakov, T.I. Pospelova, A.V. Proidakov, O.A. Rukavitsyn, G.Sh. Safuanova, I.N. Subortseva, M.S. Fominykh, M.V. Frolova, T.V. Shelekhova, D.G. Sherstnev, T.V. Shneider, V.A. Shuvaev, Z.K. Abdulkhalikova, L.V. Anchukova, I.A. Apanaskevich, A.N. Arnautova, M.V. Barabanshchikova, N.V. Berlina, A.P. Bityukov, E.A. Gilyazitdinova, V.I. Gilmanshina, E.K. Egorova, E.V. Efremova, E.B. Zhalsanova, E.N. Kabanova, O.B. Kalashnikova, A.E. Kersilova, T.I. Kolosheinova, P.M. Kondratovskii, E.V. Koroleva, A.N. Kotelnikova, N.A. Lazareva, N.S. Lazorko, E.V. Lyyurova, A.S. Lyamkina, Yu.N. Maslova, E.S. Mileeva, N.E. Mochkin, E.K. Nekhai, Ya.A. Noskov, E.S. Osipova, M.M. Pankrashkina, E.V. Potanina, O.D. Rudenko, T.Yu. Rozhenkova, E.I. Sbityakova, N.T. Siordiya, A.V. Talko, E.I. Usacheva, Yu.B. Chernykh, T.V. Chitanava, K.S. Shashkina, D.I. Shikhbabaeva, K.S. Yurovskaya
    176-197
    01.04.2022
  • Treatment of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

    Aleksander Sergeevich Luchinin
    130-139
    01.04.2022
  • Current State of Diagnosis and Treatment of Acute Myeloid Leukemias in Adult Patients in the Republic of Kazakhstan

    A.A. Klodzinskii, I.A. Pivovarova, L.G. Turgunova, Aimzhan Zharkynovna Anafina, A.V. Zinchenko
    69-75
    01.01.2022
  • Results of the Russian Multi-Center Cooperative Prospective-Retrospective Observational Program for Hodgkin’s Lymphoma Treatment RNWOHG-HD1

    Ivan Sergeevich Moiseev, S.M. Alekseev, N.B. Mikhailova, K.D. Kaplanov, M.V. Demchenkova, L.V. Anchukova, V.V. Baikov, A.M. Belyaev, Yu.A. Vasil’eva, N.P. Volkov, Yu.N. Vinogradova, A.Yu. Zaritskey, A.E. Zdorov, N.V. Il’in, L.O. Kashintseva, E.V. Kondakova, P.V. Kotselyabina, V.A. Lapin, K.V. Lepik, I.V. Lesechko, V.M. Moiseenko, G.M. Manikhas, N.V. Medvedeva, Yu.A. Oleinik, E.S. Pavlyuchenko, K.S. Parfenova, E.V. Patrakova, A.V. Proidakov, D.V. Saidullaeva, E.V. Tarasova, A.L. Shipaeva, T.V. Shneider, B.V. Afanasyev
    455-465
    01.10.2021
  • Pharmacoeconomic Analysis of R-DA-EPOCH and R-mNHL-BFM-90 Combination Immunochemotherapy in Patients with Prognostically Unfavorable Diffuse Large B-Cell Lymphoma within Randomized Multi-Center Clinical Trial DLBCL-2015

    Madina Olegovna Bagova, A.U. Magomedova, S.K. Kravchenko, R.I. Yagudina, V.G. Serpik, S.M. Kulikov, Yu.A. Chabaeva
    321-332
    01.07.2021
1 - 40 of 86 items 1 2 3 > >> 

oa-antiplagiat

Антиплагиат

Make a Submission

Make a Submission

Banner ROHS

Russian Oncohematology Society

Indexing Databases

  • ISSN
  • cyberleninka cyberleninka
  • DOAJ
  • Web of Science
  • Scopus
  • Elsevier
  • CAS Source Index (CASSI)
  • NLM Catalog
  • British Library
  • РИНЦ
  • Science Index
  • SCImago
  • The European Library
  • Scholia
  • Journal Observatory
  • Scholar Google
  • IPR Smart
  • RSL
  • Ulrich's Serials Analysis System
  • ВИНИТИ
  • WorldCat
  • Research4Life
  • Lens
  • Mendeley
  • MIAR
  • OpenCitations
  • xueshu
  • OpenAlex
  • Scilit
  • Wikidata
  • na.neicon
  • Internet Archive scholar
  • ZDB catalogue
  • Keepers ISSN
  • RusMed
  • RCSI

Editor-in-Chief

Gayane Sepugovna Tumyan

ARCHIVE

2026
  • Issue 1 (2026)
2025
  • Issue 1 (2025)
  • Issue 2 (2025)
  • Issue 3 (2025)
  • Issue 4 (2025)
2024
  • Issue 1 (2024)
  • Issue 2 (2024)
  • Issue 3 (2024)
  • Issue 4 (2024)
2023
  • Issue 1 (2023)
  • Issue 2 (2023)
  • Issue 3 (2023)
  • Issue 4 (2023)
2022
  • Issue 1 (2022)
  • Issue 2 (2022)
  • Issue 3 (2022)
  • Issue 4 (2022)
2021
  • Issue 1 (2021)
  • Issue 2 (2021)
  • Issue 3 (2021)
  • Issue 4 (2021)
2020
  • Issue 1 (2020)
  • Issue 2 (2020)
  • Issue 3 (2020)
  • Issue 4 (2020)
2019
  • Issue 1 (2019)
  • Issue 2 (2019)
  • Issue 3 (2019)
  • Issue 4 (2019)
2018
  • Issue 1 (2018)
  • Issue 2 (2018)
  • Issue 3 (2018)
  • Issue 4 (2018)
2017
  • Issue 1 (2017)
  • Issue 2 (2017)
  • Issue 3 (2017)
  • Issue 4 (2017)
2016
  • Issue 1 (2016)
  • Issue 2 (2016)
  • Issue 3 (2016)
  • Issue 4 (2016)
2015
  • Issue 1 (2015)
  • Issue 2 (2015)
  • Issue 3 (2015)
  • Issue 4 (2015)
2014
  • Issue 1 (2014)
  • Issue 2 (2014)
  • Issue 3 (2014)
  • Issue 4 (2014)
2013
  • Issue 1 (2013)
  • Issue 2 (2013)
  • Issue 3 (2013)
  • Issue 4 (2013)
ALL ARCHIVE

Keywords

Most Read Articles
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
    3439
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
    1348
  • Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis
    922
  • Multiple myeloma (pathogenesis, clinical features, diagnosis, differential diagnosis). Part I
    871
  • Anemia of Chronic Diseases
    861

Partners

Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI
Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI

«PRACTICAL MEDICINE» LLC
115201, Moscow, 1st Kotlyakovsky Pereulok 3
Phone. +7 (495) 324-93-29
E-mail: org@bloodjournal.ru
medprint.ru


Copyright © Clinical Oncohematology. Basic Research and Clinical Practice 2026

Up